Unlocking the Power of RNA for Next-Generation Diagnostics & Therapeutics

RNA expertise. AI-powered insights. Redefining disease knowledge to improve outcomes.

Value Proposition

AI-Driven Biomarker Discovery

Accelerated identification of disease-relevant RNA biomarkers.

Novel Drug Target Identification

Unmasking of new druggable nodes beyond protein-coding genes.

Customizable Data Integration

Seamless analytics and visualization for collaborative research.

Focus on Neurological & Rare Diseases

Specialized expertise in tackling conditions with significant therapy gaps.

Mission Statement

At AmarnaBio, we harness the therapeutic and diagnostic potential of RNAs. By integrating advanced machine learning with deep RNA biology, we decode the regulatory networks that drive human disease. Our mission is to deliver novel biomarkers and drug targets, thereby accelerating drug development and improving patient outcomes.

Vision

We envision contributing to a world where diseases are identified earlier, treatments are more effective, and healthcare is more targeted.

What Sets Us Apart

Our unique platform uncovers regulatory RNA networks invisible to traditional genomics.

We focus on non-coding and regulatory RNAs that confer tissue specificity and control gene expression.

Our solutions adapt across disease areas, with strengths in neurological and rare disorders.

Team Highlights

Founder and President

Vice President

Director of Research & Operations

Flagship Platform Overview

AI/ML analytics

RNA interactome decoding

Biomarker/target validation

Disease-relevant insights

How It Works

Collaboration Opportunities

We believe in the power of partnerships. AmarnaBio is open to collaborating with academic institutions, biotech firms, and pharmaceutical companies to accelerate research and developmemt.

Contact Form

Ready to explore a partnership or learn more? Fill out the form below, and our team will be in touch